LEXINGTON, Mass. & SYDNEY--(BUSINESS WIRE)--GI Dynamics, Inc. (ASX: GID), a company pioneering the development of effective, non-surgical approaches for treating type 2 diabetes and obesity, is pleased to provide its financial results for the year ended 31 December 2011. The Appendix 4E, which has been prepared in U.S. dollars, is attached; the results disclosed in the Appendix 4E are audited. Attached also find the audited consolidated financial statements for the years ended December 31, 2011, 2010 and 2009 with the Report of the Independent Registered Accounting Firm, Ernst & Young, LLP.
